From GlobeNewswire: 2025-06-10 13:33:00

MiNK Therapeutics, Inc. will hold its Annual Shareholders Meeting virtually on June 18, 2025, starting at 9:30 a.m. ET. Shareholders can register at www.virtualshareholdermeeting.com/INKT2025 with a 16-digit control number, while guests can access the meeting in listen-only mode. The webcast will be available on the company’s website. MiNK Therapeutics focuses on developing allogeneic iNKT cell therapies and immune technologies to treat various conditions. Their lead asset, AGENT-797, is currently in clinical development for graft-versus-host disease, solid tumors, and pulmonary immune collapse. For more information, visit https://minktherapeutics.com or @MiNK_iNKT.



Read more at GlobeNewswire: MiNK Therapeutics Announces Virtual Annual Shareholders